Skip to main content

Table 3 Demographics of NETs (Sample sets 1–3)

From: Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors

Sample set Sample no. Gender Age range Site Metastases Treatment#
1 T1 M 45-49 Ileum N N
1 T2 F 60-64 Ileum N N
1 T3 F 45-49 Ileum N N
1 T4 M 65-69 Ileum N N
1 T5 F 85-89 Ileum N N
1 T6 M 40-44 Ileum N N
1 T7 F 65-69 Ileum N N
1 T8 M 65-69 Ileum N N
1 T9 F 55-59 Ileum N N
2 T1 M 70-74 Ileum N N
2 T2 M 80-84 Ileocecal junction N N
2 T3 F 60-64 Ileum N N
2 T4 M 50-54 Liver* Y Y
2 T5 F 60-64 Liver* Y Y
2 T6 F 75-79 Liver* Y Y
3 T1 F 65-69 Ileum N N
3 T2 F 60-64 Ileum Y N
3 T3 M 65-69 Ileum Y Y
3 T4 M 65-69 Ileum Y Y
3 T5 F 60-64 Ileum N N
3 T6 M 75-79 Ileum N N
3 T7 F 60-64 Ileum N N
3 T8 F 55-59 Ileum N N
3 T9 M 40-44 Ileum Y N
3 T10 M 45-49 Ileum N N
3 T11 M 50-54 Ileum N N
3 T12 F 45-49 Ileum N N
3 T13 F 50-54 Ileum Y N
  1. #Treatment included somatostatin analogs and/or interferon [21].
  2. *All patients had carcinoid syndrome [21] so presumably the primary tumors were derived from the small intestine.
  3. Female = female, M = Male, N = No, Y = Yes.